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Abstract 
Cryptococcus neoformans is an important fungal pathogen of immunocompromised 
individuals.  During initial infection, C. neoformans colonizes the airspaces of the lungs, 
resulting in pneumonia, and subsequently migrates to the central nervous system (CNS). 
Previously, research has been centrally looking at the fungal carbon metabolic pathway in 
communication with the host system. In seeking to greater understand fungal carbon utilization 
in C. neoformans, a mutant strain for the pyruvate kinase gene was created. This mutant strain 
(∆pyk1) was shown from previous experiments to be avirulent. We propose inserting a gene 
into this strain that would produce the cytokine interferon-gamma, thus functioning to prevent 
infection by C. neoformans. Logically, if the addition of a gene producing the cytokine 
interferon-gamma can be properly inserted to the genome of the ∆pyk1 mutant, then the 
mutant strain could be used as a basis for a vaccine preventing immunocompromised 
individuals from developing cryptococcosis. Previous studies have shown that insertion of the 
gene for interferon-gamma into the genome of wild-type C. neoformans created a strain that 
was able to provide immunity for cryptococcosis in mice. We plan to use this model, but 
improve upon it by inserting the gene into the attenuated ∆pyk1 mutant. In order to do this, a 
plasmid containing the interferon-gamma gene will be used to eventually transform the C. 
neoformans ∆pyk1 strain. We will create this plasmid containing the interferon gamma gene. 
Primers were constructed for the amplification of the desired DNA. Infusion technique will then 
allow us to create the plasmid. Once the plasmid is created, we will move forward in the 
creation of the vaccine strain.  
 
 
